NCT00485849View on ClinicalTrials.gov

A Study of Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behaviour Problems in Children With ASD

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 29, 2004

Study Completion Date

October 31, 2004

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG

Atomoxetine Hydrochloride

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician, Groningen

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT00485849 - A Study of Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behaviour Problems in Children With ASD | Biotech Hunter | Biotech Hunter